Home
About
Overview
Sharing Data
ORCID
Help
History (20)
PEOPLE (NCT03447678), a first-line phase II pembrolizumab trial, in negative and low PD-L1 advanced NSCLC: clinical outcomes and association with circulating immune biomarkers.
Japanese single nucleotide polymorphism database for 267 possible drug-related genes.
Adolescent Sexuality.
Targeting RLIP with CRISPR/Cas9 controls tumor growth.
Principal Investigator
See All 20 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Green, William
contributes to
Different components of nicotine-induced upregulation of nicotinic receptors